ArticleMolecular therapy : the journal of the American Society of Gene Therapy2013

BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysis.

Sara Samuel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.